HALO logo
halo search icon
Bicycle Therapeutics Plc Sponsored ADR
Bicycle Therapeutics Plc Sponsored ADR
BCYC · NAS

Bicycle Therapeutics Plc Sponsored ADR

US$4.42

Price Arrow0.07 (1.61%)
20/05/2026 04:00:01 PM
All-ConsensusHammer Bullish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Bicycle Therapeutics Plc Sponsored ADR Overview

BCYC Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About BCYC

icon

Telephone

44.1223.261503

icon

Address

Blocks A & B, Portway Building, Granta Park Great Abington, Cambridge, Cambridgeshire CB21 6GS

Description

Bicycle Therapeutics Plc is a clinical-stage biopharmaceutical company, which engages in the development of a novel class of medicines, which the company refers to as bicycles, for diseases that are underserved by existing therapeutics. Its portfolio includes internal product candidates that are directed to oncology applications. The company was founded by Gregory Winter, John Tite, and Christian Heinis in 2009 and is headquartered in Cambridge, the United Kingdom.

BCYC Price Chart

Key Stats

Market Cap

US$219.12M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.24 - 9.36

Trade Value (12mth)

US$540,002.00

1 week

-2.25%

1 month

-11.76%

YTD

-34.88%

1 year

-45.96%

All time high

62.08

Key Fundamentals

EPS 3 yr Growth

-16.60%

EBITDA Margin

-380.50%

Operating Cashflow

-$250m

Free Cash Flow Return

-35.20%

ROIC

-30.90%

Interest Coverage

NaN

Quick Ratio

12.00

Other Data

Shares Outstanding (Fully Diluted)

70m

HALO Sector

Healthcare

Next Company Report Date

16-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

BCYC Announcements

Latest Announcements

DateAnnouncements
30 April 26
30 April 26
30 April 26
30 April 26
20 April 26

BCYC Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock-5.1-2.91-3.17locklocklock
EPS (Fully Diluted)
$locklocklocklock-5.1-2.91-3.17locklocklock
Growth
%locklocklocklock-34.243-9locklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS)?
Halo FAQ
The current share price of Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) is USD$4.42.
What is the 52-week high share price for Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS)?
Halo FAQ
The 52-week high share price for Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) is USD$9.36.
What is the 52-week low share price for Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS)?
Halo FAQ
The 52-week low share price for Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) is USD$4.24.
What is the dividend yield for Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS)?
Halo FAQ
Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) does not pay a dividend.
What was Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) last dividend payment?
Halo FAQ
Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) does not pay a dividend.
What is the franking level for Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS)?
Halo FAQ
Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) has a franking level of 0.00%.
In which sector is Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) classified?
Halo FAQ
Bicycle Therapeutics Plc Sponsored ADR (BCYC:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.